Filter Content:

News

EMJ

Allergy & Immunology

22 Feb 2016

Patient Enrolment Completed in US Phase IIb Study of GrassMATAMPL

Allergy Therapeutics (AIM:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announces it has completed…

EMJ

22 Feb 2016

The E. Coli Anchor: The Achilles Heel of Urinary Tract Infections

NEW vaccines could soon be developed to combat urinary tract infections (UTI), following research that has provided a detailed view of a spring-like…

EMJ

22 Feb 2016

Prostate Cancer Discovery May Lead to New Cancer Treatment

AN EXCITING discovery highlighting a link between two prostate cancer treatments has provided the basis for a potential new therapy. In addition…

EMJ

Gastroenterology

19 Feb 2016

Norgine Launches XIFAXAN® 200mg (aifaximin-α) for the Treatment of Travellers Diarrhoea in Australia

LONDON, UK, Friday 19 February, 12:00 GMT: Norgine B.V. has today announced that XIFAXAN® 200mg is now available in Australia for the treatment of…

EMJ

19 Feb 2016

Introducing the European Medical Journal 1.1

United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.

EMJ

15 Feb 2016

Mecca’s Cardiac Hospital Describes How it Copes with the Hajj

Riyadh, Saudi Arabia, 12 February 2016: Mecca’s cardiac hospital has described how it copes with the huge patient influx during the Hajj and…

EMJ

15 Feb 2016

New Drug has Potential for Neuron Preservation in Parkinson’s Disease

IMPROVED treatment for Parkinson’s disease could be on the horizon following successful trials of a new drug that can treat the condition by changing…

EMJ

15 Feb 2016

The Progress in Autism Research You ‘Aut’ To Pay Attention To

GABA, the inhibitory neurotransmitter, has been linked with autism for the first time thanks to recent advances in autism-related research.

Loading posts...

« Previous 1 … 702 703 704 705 706 … 931 Next »